Staff View for: From genome to therapy : integrating new

 Staff view

You must be logged in to Tag Records

From genome to therapy [electronic resource] : integrating new technologies with drug development /

[editors, Gregory R. Bock, Dalia Cohen, and Jamie A. Goode].

Book Cover
Names: Bock, Gregory. | Cohen, Dalia, | Goode, Jamie.
Published: Chichester ; Wiley, 2000.
Series: Novartis Foundation symposium ; 229.
Topics: Pharmacogenomics - Congresses. | Pharmacogenetics - Congresses. | Pharmacogenetics - Congresses. | Drug Design - Congresses. | Genomics - Congresses.
Genres: Electronic books. | Conference proceedings.
Online Access: Wiley Online Library - Full text
Tags: Add


Spaces will separate tags.
Use quotes for multi-word tags.


000 05082cam a2200745Ia 4500
001 7773206
003 UIUdb
005 20150630194026.0
006 m o d
007 cr cn|||||||||
008 030821s2000 enka ob 101 0 eng d
019 |a85819950|a604499442|a638660020|a638660037
020 |a047085183X|qelectronic bk.
020 |a9780470851838|qelectronic bk.
020 |z0471627445|qalk. paper
020 |z9780471627449|qalk. paper
020 |a047084664X|qelectronic bk.
020 |a9780470846643|qelectronic bk.
024 7 |a10.1002/047084664X|2doi
035 |a(OCoLC)ocm52890506
040 |aN$T|beng|epn|cN$T|dOCLCQ|dYDXCP|dOCLCG|dOCLCA|dOCLCQ|dIDEBK|dOCLCQ|dDG1|dBTCTA|dOKU|dOCLCE|dOCLCO|dOCLCF|dOCLCO|dOCLCQ|dOCLCO|dUIUdb
042 |adlr
049 |aUIUU|oskip
050 4|aRM301.3.G45|bF76 2000eb
060 4|aW1|bNO9285 v.229 2000
060 4|aQV 38|bF931 2000
082 04|a615/.19|222
245 00|aFrom genome to therapy|h[electronic resource] :|bintegrating new technologies with drug development /|c[editors, Gregory R. Bock, Dalia Cohen, and Jamie A. Goode].
260 |aChichester ;|aNew York :|bWiley,|c2000.
300 |a1 online resource (viii, 165 pages) :|billustrations.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
490 1 |aNovartis Foundation symposium ;|v229
500 |a"Symposium on From Genome to Therapy: Integrating New Technologies with Drug Development, held at the Hotel Europe, Basel, Switzerland, 22-24 June 1999"--Contents page.
504 |aIncludes bibliographical references and index.
505 00|tIntroduction /|rJ.C. Venter --|tElectrophoresis-based fluorescent dideoxy-terminator sequencing /|rJ.W. Efcavitch --|tGenomic impact on pharmaceutical development /|rJ.C. Venter --|tFrom transcription regulation to cell cycle checkpoint /|rR. Cai [and others] --|tMass spectrometry resurrects protein-based approaches in functional genomics /|rM. Mann --|tA clinical molecular scanner to study human proteome complexity /|rD. Hochstrasser [and others] --|tFrom proteomics to functional analysis /|rJ. Van Ostrum --|tMicrobial genome sequencing : new insights into physiology and evolution /|rC.M. Fraser --|tPharmacogenetics and pharmacogenetics in the discovery and development of medicines /|rA.D. Roses --|tMutagensis and genomics in the mouse : towards systematic studies of mammalian gene function /|rS.D.M. Brown --|tBiological annotation of the Drosphila genome sequence /|rG.M. Rubin --|tApplications of high-density oligonucleotide arrays /|rR.J. Lipshutz --|tPlasmodium falciparum : from genomic sequence to vaccines and drugs /|rS.L. Hoffmann and D.J. Carucci --|tFunctional analysis of the yeast genome by precise deletion and parallel phenotypic characterization /|rE.A. Winzeler [and others] --|tPatenting genes and gene therapy : legal and ethical aspects /|rJ. Straus --|tEthical issues from genome to therapy /|rD. Magnus --|tThe impact of genomics on drug discovery /|rP.N. Goodfellow --|tFrom genome to therapy : industry perspective /|rP.L. Herrling --|tFinal general discussion.
506 |3Use copy|fRestrictions unspecified|2star|5MiAaHDL
533 |aElectronic reproduction.|b[S.l.] :|cHathiTrust Digital Library,|d2010.|5MiAaHDL
538 |aMaster and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.|uhttp://purl.oclc.org/DLF/benchrepro0212|5MiAaHDL
583 1 |adigitized|c2010|hHathiTrust Digital Library|lcommitted to preserve|2pda|5MiAaHDL
588 0 |aPrint version record.
650 0|aPharmacogenomics|vCongresses.
650 0|aPharmacogenetics|vCongresses.
650 12|aPharmacogenetics|vCongresses.
650 22|aDrug Design|vCongresses.
650 22|aGenomics|vCongresses.
650 7|aPharmacogenetics.|2fast|0(OCoLC)fst01060243
650 7|aPharmacogenomics.|2fast|0(OCoLC)fst01060245
655 4|aElectronic books.
655 7|aConference proceedings.|2fast|0(OCoLC)fst01423772
700 1 |aBock, Gregory.
700 1 |aCohen, Dalia,|d1953-
700 1 |aGoode, Jamie.
710 2 |aNovartis Foundation.
711 2 |aSymposium on From Genome to Therapy: Integrating New Technologies with Drug Development|d(1999 :|cBasel, Switzerland)
776 08|iPrint version:|tFrom genome to therapy.|dChichester ; New York : Wiley, 2000|z0471627445|w(DLC) 00043348|w(OCoLC)44548923
830 0|aNovartis Foundation symposium ;|v229.
852 8 |beresour-nc|hOnline Resource|t1|zAccessible anywhere on campus or with UIUC NetID
856 40|3Wiley Online Library - Full text|uhttp://www.library.illinois.edu/proxy/go.php?url=http://dx.doi.org/10.1002/047084664X|xUIU
938 |aBaker and Taylor|bBTCP|nBK0007268898
938 |aEBSCOhost|bEBSC|n83678
938 |aYBP Library Services|bYANK|n2297031
938 |aYBP Library Services|bYANK|n2942162
994 |aC0|bUIU

Staff View for: From genome to therapy : integrating new